← Back
This reengineered HPV vaccine trains T cells to hunt down cancer
General • February 18, 2026
Northwestern cancer-immunotherapy-recovering-cells-is-key-ndian-researchers-may-have-found-a-way'>researchers have shown that when it comes to cancer
vaccines,
arrangement can be just as
important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune system’s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components.
Related Articles
Source: Original →